Dotbio announced the completion of tens of millions of yuan Pre-A round financing

Titanium Media APP August 10 news, Dotbio, a biopharmaceutical company, announced the completion of tens of millions of yuan Pre-A round financing. This round of financing was led by neighboring Star Venture Capital, Gao Rong Capital, and AIM-HI Accelerator Fund. This round of financing funds will be used to carry out preclinical research, including the research of animal curative effects, as well as chemical, manufacturing and control research to help verify the potential of candidate therapeutic drugs to promote the clinical stage in the future.